News
In its Friday approval letter, the FDA didn’t explain the restrictions although they reflect skepticism about ...
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
The U.S. Food and Drug Administration on Friday approved Novavax's COVID-19 vaccine, but placed additional conditions on ...
Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.
The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...
Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an ...
With new testing requirements, it’s not even clear whether new Covid or flu shots can be made available this fall.
The Mississippi Attorney General's Office is waiting to see how much a judge will award the state in a lawsuit with the ...
U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive suggesting its research ...
The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results